Table 12.11

Adjusted Patient Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 2,032 91.4% 0.6% 2,032 83.2% 0.8% 3,962 64.1% 0.9% 5,620 48.2% 1.0%
Primary Diagnosis Emphysema/COPD 818 93.7% 0.9% 818 86.2% 1.3% 1,689 66.3% 1.5% 2,392 50.0% 1.6%
Cystic Fibrosis 316 93.4% 1.5% 316 83.6% 2.5% 618 64.1% 2.8% 886 48.4% 2.7%
Idiopathic Pulmonary Fibrosis 436 89.0% 1.5% 436 80.6% 2.0% 734 62.9% 2.2% 1,011 43.9% 2.4%
Alpha-1-Antitrypsin Deficiency 142 91.5% 2.3% 142 83.0% 3.2% 291 65.3% 3.2% 421 46.0% 3.5%
Primary Pulmonary Hypertension 88 75.6% 4.8% 88 74.5% 4.8% 161 57.3% 4.7% 239 55.3% 3.8%
Congenital Disease 19 84.2% 8.5% 19 84.2% 8.5% 40 55.0% 10.1% 70 46.3% 7.2%
Other 211 90.5% 2.0% 211 77.6% 2.9% 426 63.0% 2.8% 594 50.5% 2.8%
Unknown 2 0.0% 0.0% 2 0.0% 0.0% 3 0.0% 0.0% 7 41.8% 16.7%


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.